Stroke Care Trends During COVID-19 Pandemic in Zanjan Province, Iran. From the CASCADE Initiative: Statistical Analysis Plan and Preliminary Results
- PMID: 33069086
- PMCID: PMC7494258
- DOI: 10.1016/j.jstrokecerebrovasdis.2020.105321
Stroke Care Trends During COVID-19 Pandemic in Zanjan Province, Iran. From the CASCADE Initiative: Statistical Analysis Plan and Preliminary Results
Abstract
Background: The emergence of the COVID-19 pandemic has significantly impacted global healthcare systems and this may affect stroke care and outcomes. This study examines the changes in stroke epidemiology and care during the COVID-19 pandemic in Zanjan Province, Iran.
Methods: This study is part of the CASCADE international initiative. From February 18, 2019, to July 18, 2020, we followed ischemic and hemorrhagic stroke hospitalization rates and outcomes in Valiasr Hospital, Zanjan, Iran. We used a Bayesian hierarchical model and an interrupted time series analysis (ITS) to identify changes in stroke hospitalization rate, baseline stroke severity [measured by the National Institutes of Health Stroke Scale (NIHSS)], disability [measured by the modified Rankin Scale (mRS)], presentation time (last seen normal to hospital presentation), thrombolytic therapy rate, median door-to-needle time, length of hospital stay, and in-hospital mortality. We compared in-hospital mortality between study periods using Cox-regression model.
Results: During the study period, 1,026 stroke patients were hospitalized. Stroke hospitalization rates per 100,000 population decreased from 68.09 before the pandemic to 44.50 during the pandemic, with a significant decline in both Bayesian [Beta: -1.034; Standard Error (SE): 0.22, 95% CrI: -1.48, -0.59] and ITS analysis (estimate: -1.03, SE = 0.24, p < 0.0001). Furthermore, we observed lower admission rates for patients with mild (NIHSS < 5) ischemic stroke (p < 0.0001). Although, the presentation time and door-to-needle time did not change during the pandemic, a lower proportion of patients received thrombolysis (-10.1%; p = 0.004). We did not see significant changes in admission rate to the stroke unit and in-hospital mortality rate; however, disability at discharge increased (p < 0.0001).
Conclusion: In Zanjan, Iran, the COVID-19 pandemic has significantly impacted stroke outcomes and altered the delivery of stroke care. Observed lower admission rates for milder stroke may possibly be due to fear of exposure related to COVID-19. The decrease in patients treated with thrombolysis and the increased disability at discharge may indicate changes in the delivery of stroke care and increased pressure on existing stroke acute and subacute services. The results of this research will contribute to a similar analysis of the larger CASCADE dataset in order to confirm findings at a global scale and improve measures to ensure the best quality of care for stroke patients during the COVID-19 pandemic.
Keywords: COVID-19; Disability; Epidemiology; Mortality; Outcome; Stroke; Stroke care.
Copyright © 2020 Elsevier Inc. All rights reserved.
Figures


Similar articles
-
The impact of COVID-19 on acute ischemic stroke admissions: Analysis from a community-based tertiary care center.J Stroke Cerebrovasc Dis. 2020 Dec;29(12):105344. doi: 10.1016/j.jstrokecerebrovasdis.2020.105344. Epub 2020 Sep 25. J Stroke Cerebrovasc Dis. 2020. PMID: 33049464 Free PMC article.
-
Stroke Code Presentations, Interventions, and Outcomes Before and During the COVID-19 Pandemic.Stroke. 2020 Sep;51(9):2664-2673. doi: 10.1161/STR.0000000000000347. Epub 2020 Jul 31. Stroke. 2020. PMID: 32755347 Free PMC article.
-
Patient Characteristics and Outcomes Associated with Decline in Stroke Volumes During the Early COVID-19 Pandemic.J Stroke Cerebrovasc Dis. 2021 Jun;30(6):105569. doi: 10.1016/j.jstrokecerebrovasdis.2020.105569. Epub 2020 Dec 26. J Stroke Cerebrovasc Dis. 2021. PMID: 33862541 Free PMC article.
-
Changes in Stroke Hospital Care During the COVID-19 Pandemic: A Systematic Review and Meta-Analysis.Stroke. 2021 Nov;52(11):3651-3660. doi: 10.1161/STROKEAHA.121.034601. Epub 2021 Aug 4. Stroke. 2021. PMID: 34344166 Free PMC article.
-
Recent Advances in Nanomedicine for Ischemic and Hemorrhagic Stroke.Stroke. 2019 May;50(5):1318-1324. doi: 10.1161/STROKEAHA.118.022744. Stroke. 2019. PMID: 30932782 Review. No abstract available.
Cited by
-
Rapid outpatient transient ischemic attack clinic and stroke service activity during the SARS-CoV-2 pandemic: a multicenter time series analysis.Front Neurol. 2024 Feb 7;15:1351769. doi: 10.3389/fneur.2024.1351769. eCollection 2024. Front Neurol. 2024. PMID: 38385034 Free PMC article.
-
Request of hospital care dropped for TIA but remained stable for stroke during COVID-19 pandemic at a large Italian university hospital.Intern Emerg Med. 2021 Apr;16(3):735-739. doi: 10.1007/s11739-020-02522-w. Epub 2020 Oct 15. Intern Emerg Med. 2021. PMID: 33063236 Free PMC article.
-
SARS-CoV-2 Is a Culprit for Some, but Not All Acute Ischemic Strokes: A Report from the Multinational COVID-19 Stroke Study Group.J Clin Med. 2021 Mar 1;10(5):931. doi: 10.3390/jcm10050931. J Clin Med. 2021. PMID: 33804307 Free PMC article.
-
The impact of the COVID-19 pandemic on cerebrovascular disease.Semin Vasc Surg. 2021 Jun;34(2):20-27. doi: 10.1053/j.semvascsurg.2021.05.001. Epub 2021 May 20. Semin Vasc Surg. 2021. PMID: 34144743 Free PMC article. Review.
-
Association of the COVID-19 pandemic on stroke admissions and treatment globally: a systematic review.BMJ Open. 2023 Mar 17;13(3):e062734. doi: 10.1136/bmjopen-2022-062734. BMJ Open. 2023. PMID: 36931673 Free PMC article.
References
-
- Adhanom Ghebreyesus T. We now have a name for the disease caused by the novel coronavirus: COVID-19 [Internet]. twitter . 2020 [cited 2020 Jul 22]. Available from: https://twitter.com/DrTedros/status/1227297754499764230.
-
- Martinez R, Lloyd-Sherlock P, Soliz P, Ebrahim S, Vega E, Ordunez P. Trends in premature avertable mortality from non-communicable diseases for 195 countries and territories, 1990-2017: a population-based study. Lancet Glob Health. 2020;8(4):e511–e523. - PubMed